Technical Analyst, Rajat K Bose is of the view that one can buy Biocon.
Bose told CNBC-TV18, "One can buy into Biocon. This is another Indian pharma company and it is likely to move up to something like Rs 556 levels. If it crosses that then it can even move up further. But for now one can go long in it because its performance seems to be pretty good technically speaking."
Link to the article: http://www.moneycontrol.com/india/news/stocks-views/buy-biocon:-bose/342653
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment